RocketTickers

Immunomedics Announces FDA Approval of Samsung Biologics as Anti

做多
NASDAQ:IMMU   None
IMMU: Immunomedics
2020-08-17 08:00:10
Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。